- Home
- CELU vs ABAT Comparison
CELU vs ABAT Comparison
Compare CELU & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- ABAT
- Stock Information
- Founded
- CELU 2016
- ABAT 2011
- Country
- CELU United States
- ABAT United States
- Employees
- CELU N/A
- ABAT N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- ABAT Metal Mining
- Sector
- CELU Health Care
- ABAT Basic Materials
- Exchange
- CELU Nasdaq
- ABAT Nasdaq
- Market Cap
- CELU 65.7M
- ABAT 61.5M
- IPO Year
- CELU N/A
- ABAT N/A
- Fundamental
- Price
- CELU $2.81
- ABAT $1.05
- Analyst Decision
- CELU
- ABAT
- Analyst Count
- CELU 0
- ABAT 0
- Target Price
- CELU N/A
- ABAT N/A
- AVG Volume (30 Days)
- CELU 12.5K
- ABAT 221.1K
- Earning Date
- CELU 09-17-2024
- ABAT 09-17-2024
- Dividend Yield
- CELU N/A
- ABAT N/A
- EPS Growth
- CELU N/A
- ABAT N/A
- EPS
- CELU N/A
- ABAT N/A
- Revenue
- CELU $22,771,000.00
- ABAT N/A
- Revenue This Year
- CELU N/A
- ABAT N/A
- Revenue Next Year
- CELU $233.89
- ABAT $1,688.76
- P/E Ratio
- CELU N/A
- ABAT N/A
- Revenue Growth
- CELU 26.68
- ABAT N/A
- 52 Week Low
- CELU $1.59
- ABAT $0.75
- 52 Week High
- CELU $7.97
- ABAT $13.78
- Technical
- Relative Strength Index (RSI)
- CELU 43.84
- ABAT 50.76
- Support Level
- CELU $2.60
- ABAT $1.04
- Resistance Level
- CELU $2.93
- ABAT $1.09
- Average True Range (ATR)
- CELU 0.21
- ABAT 0.05
- MACD
- CELU -0.02
- ABAT 0.00
- Stochastic Oscillator
- CELU 29.11
- ABAT 33.58
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.